Wendy K. Wee
2012
In 2012, Wendy K. Wee earned a total compensation of $236K as Vice President, Finance and Controller at MabVax Therapeutics Holdings, a 41% decrease compared to previous year.
Compensation breakdown
| Salary | $236,000 |
|---|---|
| Total | $236,000 |
Wee received $236K in salary, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Wendy K. Wee's compensation ranked 10,623rd out of 11,487 executives tracked by ExecPay. In other words, Wee earned more than 7.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,623 out of 11,487 | 8th |
Division Manufacturing | 3,947 out of 4,253 | 7th |
Major group Chemicals And Allied Products | 1,103 out of 1,198 | 8th |
Industry group Drugs | 847 out of 920 | 8th |
Industry Pharmaceutical Preparations | 644 out of 700 | 8th |
Source: SEC filing on April 5, 2013.
Wee's colleagues
We found four more compensation records of executives who worked with Wendy K. Wee at MabVax Therapeutics Holdings in 2012.
2012
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2012
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2012
Steven Schow
MabVax Therapeutics Holdings
Vice President, Research
2012
Marc Steuer
MabVax Therapeutics Holdings